Working… Menu

DETECT IV - A Study in Patients With HER2-negative Metastatic Breast Cancer and Persisting HER2-negative Circulating Tumor Cells (CTCs).

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02035813
Recruitment Status : Recruiting
First Posted : January 14, 2014
Last Update Posted : October 25, 2019
Information provided by (Responsible Party):
Prof. W. Janni, University of Ulm

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2020
Study Completion Date : December 2022